EntroGen has launched the Leukemia Translocation panel. It is a multiplexed, one-step real-time PCR assay that detects eleven variants in 6 common leukemia associated translocations simultaneously. The panel detects and identifies AML1-ETO, CBFB-MYH11, MLL-AF4, TEL-AML1, E2A-PBX1, and PML-RARA fusion gene transcripts from total RNA isolated from blood or bone marrow. The product is compatible with several leading multi-channel real-time PCR instruments capable of detecting four commonly used fluorescent probes and produces results in just 90 minutes, the company said. It can also be run together with the company's p190 and p120 real-time PCR kits for a comprehensive test for fusion genes implicated in CML, ALL, APL, and AML, the company said.